Crenezumab (Anti-Amyloid Beta)
Crenezumab (Anti-Amyloid Beta) is a fully humanized immunoglobulin (Ig) G4 monoclonal antibody that targets amyloid beta (Abeta) with potential for use in Alzheimer's disease research. MW: 143.58 kD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2764 |
| Sku # | A2764-1mg*5 |
| Pricing | 1mg*5, $1690.00 |